During the past decade, ARNAS Civico conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ARNAS Civico" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "European Institute of Oncology" with 2 trials sponsored, "Gruppo di Ricerca GISSI" with 2 trials sponsored, "Italian Sarcoma Group" with 2 trials sponsored and "Azienda Ospedaliera Universitaria Integrata Verona" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ARNAS Civico" #1 collaborator was "Associazione Italiana Ematologia Oncologia Pediatrica" with 1 trials as a collaborator, "Averion International Corporation" with 1 trials as a collaborator, "Biotronik Italia" with 1 trials as a collaborator, "Boston Scientific; Pr Olivier Varenne" with 1 trials as a collaborator and "PharmaMar" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "ARNAS Civico" are "Chronic Renal Failure" (2 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials), "Abdominal Aortic Aneurysm" (1 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "ARNAS Civico" in a lesser frequency.

Most popular intervention types in "ARNAS Civico" are "Drug" (11 trials), "Device" (5 trials), "Other" (3 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "25-OH-D vitamin" (1 trials), "Carbamazepine" (1 trials), "Carboplatin" (1 trials) and "Erythropoiesis Stimulating Agents (ESAs): epoetin alfa, beta or any other epoetin in equivalent dose." (1 trials). Other intervention names were less common.

The vast majority of trials in "ARNAS Civico" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "ARNAS Civico". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in ARNAS Civico, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ARNAS Civico, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

ARNAS Civico has several departments that took part in Clinical trials: "A.R.N.A.S. Civico Di Cristina Benfratelli; U.O.C. Neurologia con Stroke Unit" - 2 trials, "ARNAS-Ospedale Civico Maurizio Ascoli; Unità Operativa di Oncologia Medica" - 2 trials